Summary

High-intensity targeted ultrasound therapy market is anticipated to be worth around US$ 194.18 Million by 2030, as according to Renub Research. High-Intensity Focused Ultrasound (HIFU) therapy is a modern-day scientific approach gaining prominence for its non-invasive method. HIFU objectives specific tissues with the aid of using particular ultrasound waves, generating heat for therapeutic applications without damaging surrounding areas. Widely used for situations like prostate cancer and uterine fibroids, HIFU minimizes healing instances and side effects compared to standard medications. Its reputation stems from its precision, decreased invasiveness, and capability programs in various medical fields. As demand for non-surgical interventions rises, HIFU emerges as a transformative technology, using advancements within the clinical panorama with its effectiveness and minimum impact on patients.


High Intensity Ultrasound Therapy market is expected to grow at a CAGR of 7.70% from 2024 to 2030

Cancer rates are disproportionately excessive in developing nations, affecting about One in Three people all through their lifetime, as per the Global Burden of Diseases (GBD). Uterine fibroids, 77% of ladies of age 50, contribute notably to global healthcare demanding challenges, with an expected 226.05 Million cases. The growing elderly populace and the surge in chronic diseases are escalating global healthcare expenditure. High-Intensity Focused Ultrasound (HIFU) is an attractive response for healthcare companies and payers, offering cost effectiveness and minimally invasive interventions. The increasing cognizance of HIFU's benefits, supported by mounting scientific proof, drives increasing demand among patients and healthcare professionals, propelling the HIFU therapy market increase.

Further, High-depth, focused ultrasound stands at the forefront of clinical innovation, poised to transform disease treatment tactics. Precisely concentrating on particular tissues with high-frequency sound waves, HIFU provides a minimally invasive and regularly curative opportunity to conventional surgery and radiation therapy. Technological strides propel the sector's increase, providing real-time imaging improvements, robot structures improving targeting accuracy, and modern transducer designs allowing deeper tissue penetration. Advanced software programs aid treatment planning, while A.I. explores customized optimization. Expanding beyond cancer, HIFU shows promise in diverse applications sponsored by developing clinical evidence. Emerging trends include closed-loop structures, combination therapies, and the potential miniaturization of gadgets, positioning HIFU as a mainstream healing alternative with ongoing interesting innovations for advanced patient care and results. Hence, the High-Intensity Focused Ultrasound Therapy Market was valued at US$ 115.55 Million in 2023.

Besides, regulatory approvals are pivotal for HIFU technology, boosting credibility and spurring investor confidence, prompting improved investment in research, improvement, and commercialization. Beyond confidence-building, approvals broaden HIFU's market reach by endorsing new applications, tapping into untapped patient populations, diversifying treatments, and adding revenue streams. Examples encompass U.S. Food and Drug Administration (FDA) approvals for chronic tremor, prostate cancer, uterine fibroids, and persistent pain, European Medicines Agency (EMA) acclaim for uterine fibroids, and Chinese Food and Drug Administration (CFDA) approval for liver cancer, pancreatic cancer, and bone tumors. The HIFU market's expansion into aesthetic applications, like skin tightening and fat removal, similarly propels usual growth.


In the dynamic realm of medical technology, HIFU (high-depth targeted ultrasound) therapy, particularly the MRI HIFU variant, is gaining prominence

The high-intensity focused ultrasound therapy market is divided into ultrasound HIFU therapy and MRI HIFU therapy by imaging technology. This innovative technique seamlessly integrates MRI steering into the HIFU process, driving a sizeable increase in the global HIFU market. Studies indicate advanced success rates and lower headaches for MRI HIFU, especially in complicated cases, preserving its minimally invasive nature and lowering restoration times and hospitalization rates. Its precision expands applications across numerous conditions like prostate cancer, liver tumors, uterine fibroids, and critical tremors.

Continuous technological improvements in MRI and HIFU transducers shape the market's trajectory, enhancing accuracy and efficacy. Mounting clinical evidence supports the protection and effectiveness of MRI HIFU, fostering wider adoption by healthcare providers. Increased focus has precipitated heightened funding, contributing to the ongoing growth and promising future outlook of the MRI HIFU market.


Prostate cancer stands as a formidable force in medical innovation, asserting itself as the HIFU (high-intensity focused ultrasound) leader

By application, the High-Intensity Focused Ultrasound Therapy Market is fragmented into Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics, and Others. Prostate cancer, the most common cancer globally, drives the demand for HIFU (high-depth focused ultrasound) due to its minimally invasive technique, proven efficacy in early-level cases, and non-surgical benefits for faster healing. HIFU's non-surgical benefits, which include more rapid healing and minimal blood loss, appeal to those seeking minimum invasive options. Its versatility in preliminary remedy, salvage therapy, and palliation widens its utility. Technological improvements, especially in real-time imaging and energy delivery, enhance accuracy, efficacy, and safety, ensuring HIFU stays competitive. Increasing attention amongst patients and healthcare professionals drives market demand, while a supportive regulatory environment, spotting HIFU's potential and approving new applications, propels expansion and fosters innovation.


Hospitals wield significant influence in the global HIFU (high-intensity focused ultrasound) market, serving as pivotal hubs for effective HIFU system operation

By end-user, the High-Intensity Focused Ultrasound Therapy Market is broken up into Diagnostic Centers, Hospitals, Research Centers, and Others. Hospitals seamlessly combine HIFU into their medical specialties, consisting of urology, oncology, and pain control, possessing dedicated remedy facilities, trained employees, superior imaging, and sturdy infrastructure. Hospitals channel patients to HIFU remedies as referral centers, creating a captive audience. Their monetary assets permit full-size investments in HIFU devices, ensuring consistent access. Leading hospitals actively contribute to HIFU research, fostering innovation and improving therapy protocols. Also, their regulatory compliance, protection protocols, and role in compensation negotiations solidify their dominance in steering the global HIFU market.


U.S. leads HIFU technology improvement, pushed by top research institutions and clinical tool corporations, fostering a competitive edge

By country, the High-Intensity Focused Ultrasound Therapy Market is categorized into United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa and Rest of World. Early contributions and ongoing improvements bolster U.S. producers, with the FDA's sturdy regulatory framework instilling self-assurance and promoting widespread HIFU adoption in the healthcare system. High U.S. healthcare rates facilitate the speedy adoption of modern-day technologies by hospitals. The state's vital research and improved infrastructure drives HIFU innovation, attracting investment and talent.

Aligned with the healthcare system's preference for minimally invasive methods, HIFU's non-surgical technique fits situations like prostate cancer and uterine fibroids. Growing public focus, fuelled by media and advocacy, propels HIFU demand, encouraging healthcare companies to combine it prominently. The favorable repayment panorama incentivizes hospitals and vendors to embody HIFU readily.


Competitive Landscape

Koninklijke Philips N.V., Johnson & Johnson, Hitachi Ltd., General Electrics, Medtronic Plc., Stryker, EDAP TMS S.A, and Theraclion are prominent players in the High Intensity Focused Ultrasound Therapy Market.


Renub Research report titled "High Intensity Focused Ultrasound Therapy Market Forecast by imaging technology (Ultrasound HIFU Therapy, and MRI HIFU Therapy), application (Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics, and Others), end-user (Diagnostic Centers, Hospitals, Research Centers, and Others), country (United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa, and Rest of the World), company (Koninklijke Philips N.V., Johnson & Johnson, Hitachi Ltd., General Electrics, Medtronic Plc., Stryker, EDAP TMS S.A, and Theraclion)" provides a detailed and comprehensive insight of the High Intensity Focused Ultrasound Therapy Industry.


Imaging Technology – High Intensity Focused Ultrasound Therapy Market breakup from 2 viewpoints:

1. Ultrasound HIFU Therapy
2. MRI HIFU Therapy


Application – High Intensity Focused Ultrasound Therapy Market breakup from 5 viewpoints:

1. Prostate Cancer
2. Uterine Fibroids
3. Neurological Disorders
4. Aesthetics
5. Others


End-User – High Intensity Focused Ultrasound Therapy Market breakup from 4 viewpoints:

1. Diagnostic Centers
2. Hospitals
3. Research Centers
4. Others


Country – Breakup from 26 Country High Intensity Focused Ultrasound Therapy Market:

1. North America

1.1 United States
1.2 Canada

2. Europe

2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey

3. Asia – Pacific

3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand

4. Latin America

4.1 Brazil
4.2 Mexico
4.3 Argentina

5. Middle East & Africa

5.1 Saudi Arabia
5.2 UAE
5.3 South Africa

6. Rest of the World


All companies have been covered from 3 viewpoints:

• Overview
• Recent Development
• Revenue


Company Analysis:

1. Koninklijke Philips N.V.
2. Johnson & Johnson
3. Hitachi Ltd.
4. General Electrics
5. Medtronic Plc.
6. Stryker
7. EDAP TMS S.A,
8. Theraclion

ページTOPに戻る

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. High Intensity Focused Ultrasound Therapy Market

6. Market Share – High Intensity Focused Ultrasound Therapy Market

6.1 By Imaging Technology
6.2 By Application
6.3 By End User
6.4 By Countries


7. Imaging Technology – High Intensity Focused Ultrasound Therapy Market

7.1 Ultrasound HIFU Therapy
7.2 MRI HIFU Therapy


8. Application – High Intensity Focused Ultrasound Therapy Market

8.1 Prostate Cancer
8.2 Uterine Fibroids
8.3 Neurological Disorders
8.4 Aesthetics
8.5 Others


9. End User – High Intensity Focused Ultrasound Therapy Market

9.1 Diagnostic Centers
9.2 Hospitals
9.3 Research Centers
9.4 Others


10. Countries – High Intensity Focused Ultrasound Therapy Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherland
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa

10.6 Rest of the World


11. Porter’s Five Forces Analysis – High Intensity Focused Ultrasound Therapy Market

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis – High Intensity Focused Ultrasound Therapy Market

12.1.1 Strength
12.1.2 Weakness
12.1.3 Opportunity
12.1.4 Threat


13. Key Players Analysis

13.1 Koninklijke Philips N.V.

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue Analysis

13.2 Johnson & Johnson

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue Analysis

13.3 Hitachi Ltd.

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue Analysis

13.4 General Electrics

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue Analysis

13.5 Medtronic Plc.

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue Analysis

13.6 Stryker

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue Analysis

13.7 EDAP TMS S.A

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue Analysis

13.8 Theraclion

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Revenue Analysis

ページTOPに戻る

List of Tables/Graphs

Table-01: Global – High Intensity Focused Ultrasound (HIFU) Therapy Market Share by Imaging Technology (Percent), 2018 – 2023
Table-02: Global – Forecast for High Intensity Focused Ultrasound (HIFU) Therapy Market Share by Imaging Technology (Percent), 2024 – 2030
Table-03: Global – High Intensity Focused Ultrasound (HIFU) Therapy Market Share by Application (Percent), 2018 – 2023
Table-04: Global – Forecast for High Intensity Focused Ultrasound (HIFU) Therapy Market Share by Application (Percent), 2024 – 2030
Table-05: Global – High Intensity Focused Ultrasound (HIFU) Therapy Market Share by End User (Percent), 2018 – 2023
Table-06: Global – Forecast for High Intensity Focused Ultrasound (HIFU) Therapy Market Share by End User (Percent), 2024 – 2030
Table-07: Global – High Intensity Focused Ultrasound (HIFU) Therapy Market Share by Countries (Percent), 2018 – 2023
Table-08: Global – Forecast for High Intensity Focused Ultrasound (HIFU) Therapy Market Share by Countries (Percent), 2024 – 2030